Filters
Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) vaccines in ...
Immunology
- 2022 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
Immunization against pneumococcal diseases
Immunization against pneumococcal diseases is important part of immunization calendars of developed countries. Mass immunization with conjugated pneumococcal vaccine is predicted in the Czech Republic since January...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2008 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Broader protection of infants and children against pneumococcal infections with a new 13-valent conjugate vaccine - Prevenar 13
Pneumococcal infections cause infant and small children morbidity and mortality even in developed countries. During the last decade, three conjugate pneumococcal 13,containing the broadest serotype coverage, is the...
FG - Pediatrie
- 2010 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Broader protection of infants and children against oneumococcal infections with a new -valent conjugate vaccine - Prevenar
Pneumococcal infections cause infant and small children morbidity and mortality even in developed countries. During the last decade, three conjugate pneumococcal 13,containing the broadest serotype coverage, is the...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2010 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
10valent pneumococcal conjugated vaccine (Synflorix)
Pneumococcal whole-cell vaccines have been developed in the early 1900s, however, pneumococcal conjugated vaccines (PCV), which are effective in infants available: a 10-valent (Synflorix) and a
FC - Pneumologie
- 2015 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults
for PCV7 vaccination. Since 2010, a 13-valent pneumococcal conjugate vaccine (PCV13 the introduction of a hepta-valent pneumococcal conjugate vaccine (PCV7). A...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2013 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
New options for use of pneumococcal conjugate vaccine in adults - indications from age 50
, the elderly and chronically ill people, the importance of pneumococcal vaccination in adultsis increasing. In October 2011, a new indication of 13-valent pneumococcal conjugate vaccine ...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2012 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered dexavalent
infants to receive either the 11-valent pneumococcal protein D (PD)-conjugate study hexavalent DTPa-HBV-IPV/Hib vaccine. The pneumococcal PD-conjugate study vaccine did. The incidence of...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2008 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Regional Advisory Board Position Statement on Optimal Pneumococcal Vaccination in adults Update to 2011 Consensus on Adult Pneumococcal Disease: Update on Optimal Pneumococcal Vaccination in Adults
-valent pneumococcal conjugate vaccine (PCV13) for adults aged 50 years and older recommendations in the Region: the availability of a pneumococcal conjugate vaccine for adults, and thefu...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2013 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
The risk group vaccination against pneumococcal diseases
vaccinations in the sense of decreasing incidence of invasive pneumococcal infections patients is of great importance here. Two types of vaccine are available - conjugated 13-valent and polysacch...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2013 •
- Jx •
- Link
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
- 1 - 10 out of 21 646